Pages with the fewest revisions

From IDWiki

Showing below up to 500 results in range #501 to #1,000.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. CR:DOI:533fdca5d7624a0a92c34442ff9c6b94‏‎ (1 revision)
  2. Enterobius vermicularis‏‎ (1 revision)
  3. Anti-nuclear antibody‏‎ (1 revision)
  4. Mental state exam‏‎ (1 revision)
  5. Howell-Jolly body‏‎ (1 revision)
  6. CR:DOI:62ad3dd3dc742a32dd360c00b0f1fa4e‏‎ (1 revision)
  7. Epworth Sleepiness Scale‏‎ (1 revision)
  8. Microorganisms with characteristic smell‏‎ (1 revision)
  9. CR:DOI:7988f4e33cb568e454f460cedbaa2940‏‎ (1 revision)
  10. Euthyroid sick syndrome‏‎ (1 revision)
  11. Arthrocentesis of the knee‏‎ (1 revision)
  12. Vericiguat‏‎ (1 revision)
  13. Mollicutes‏‎ (1 revision)
  14. CR:DOI:8cf276af02c1dee0d890220e9c4da472‏‎ (1 revision)
  15. Simian vacuolating virus 40‏‎ (1 revision)
  16. Inappropriate sinus tachycardia‏‎ (1 revision)
  17. CR:DOI:9e3503306da31f0700db99291beb5a46‏‎ (1 revision)
  18. Wound swab‏‎ (1 revision)
  19. Mycobacterium haemophilum‏‎ (1 revision)
  20. Infections associated with fish‏‎ (1 revision)
  21. CR:DOI:b2fbffadb731b73f5d5ca77aa60b3402‏‎ (1 revision)
  22. Post-polio syndrome‏‎ (1 revision)
  23. CR:DOI:c605aab953141c2376f3b8840f0d6d24‏‎ (1 revision)
  24. Status epilepticus‏‎ (1 revision)
  25. Near miss‏‎ (1 revision)
  26. GATA2 deficiency‏‎ (1 revision)
  27. CR:DOI:d0cf721f1b11c4947d9d584119e157fa‏‎ (1 revision)
  28. Nephrotic syndrome‏‎ (1 revision)
  29. Irregular periods‏‎ (1 revision)
  30. Gemtuzumab ozogamicin‏‎ (1 revision)
  31. de Winter syndrome‏‎ (1 revision)
  32. Superior vena cava syndrome‏‎ (1 revision)
  33. Dermatobia hominis‏‎ (1 revision)
  34. CR:DOI:f3a34c3cfd0c645bb74d5a5110a3c1db‏‎ (1 revision)
  35. Lacticaseibacillus paracasei‏‎ (1 revision)
  36. Opioid risk tool‏‎ (1 revision)
  37. CR:DOI:0bf8ee2ef119a747eb1ef476f7e7b719‏‎ (1 revision)
  38. Dominant R-wave in aVR‏‎ (1 revision)
  39. Tobacco, alcohol, prescription medication, and other substance use tool‏‎ (1 revision)
  40. Osimertinib‏‎ (1 revision)
  41. CR:DOI:2030b67e3e5ece9bb99885a6c6b65add‏‎ (1 revision)
  42. Cardiac metastases‏‎ (1 revision)
  43. PAMC‏‎ (1 revision)
  44. CR:DOI:313b2c31a000cc7719c112463f068c86‏‎ (1 revision)
  45. Alemtuzumab‏‎ (1 revision)
  46. MRC Strength Grades‏‎ (1 revision)
  47. CR:DOI:45fdd9d93c8d6c80b99b6f38d0dccd38‏‎ (1 revision)
  48. Risankizumab‏‎ (1 revision)
  49. McCune-Albright syndrome‏‎ (1 revision)
  50. CR:DOI:54261e0f60b000f250d27de501384afa‏‎ (1 revision)
  51. Antibiograms‏‎ (1 revision)
  52. Urinoma‏‎ (1 revision)
  53. SPRINT Frailty Index‏‎ (1 revision)
  54. Mentation‏‎ (1 revision)
  55. CR:DOI:644b0ce19e450a09f9761d4c0febe015‏‎ (1 revision)
  56. Eravacycline‏‎ (1 revision)
  57. Chronic palatal or nasal septal destruction‏‎ (1 revision)
  58. Perioperative infective endocarditis prophylaxis‏‎ (1 revision)
  59. CR:DOI:7a71a1068c5ec01ab6e0764dcec5f8c2‏‎ (1 revision)
  60. Exercise-induced vasculitis‏‎ (1 revision)
  61. Serious illness conversation guide‏‎ (1 revision)
  62. CR:DOI:8e2bad092ff079112b6816a5cc9f7230‏‎ (1 revision)
  63. Fagerström test‏‎ (1 revision)
  64. Platelet function assay‏‎ (1 revision)
  65. Multiple endocrine neoplasia‏‎ (1 revision)
  66. CR:DOI:9e91b940cf2d14742e8ff93036e10367‏‎ (1 revision)
  67. Fever in a critically ill patient‏‎ (1 revision)
  68. Sorafenib‏‎ (1 revision)
  69. Polycystic ovarian syndrome‏‎ (1 revision)
  70. CR:DOI:b4c581c4c9d64c391ae075e32142b7d3‏‎ (1 revision)
  71. Post-transfusion purpura‏‎ (1 revision)
  72. Myocardial infarction after noncardiac surgery‏‎ (1 revision)
  73. CR:DOI:c6b0b2592ddf24cc5b656bbc4bbc13b2‏‎ (1 revision)
  74. Stemmer sign‏‎ (1 revision)
  75. Necrotizing enterocolitis‏‎ (1 revision)
  76. GBS‏‎ (1 revision)
  77. Cyclic neutropenia‏‎ (1 revision)
  78. CR:DOI:d236bdb9afe11cd60f12e3273f0048b2‏‎ (1 revision)
  79. Propofol infusion syndrome‏‎ (1 revision)
  80. Neurodegenerative disorder‏‎ (1 revision)
  81. CR:DOI:e27c5a4887971b847d54ab78959726af‏‎ (1 revision)
  82. Good Clinical Practices‏‎ (1 revision)
  83. Dermatologic manifestations of celiac disease‏‎ (1 revision)
  84. CR:DOI:f4577849ce48a1dcf269d14f81fe5c63‏‎ (1 revision)
  85. CMV in HIV patients‏‎ (1 revision)
  86. CR:PMID:3867865‏‎ (1 revision)
  87. Thrombotic thrombocytopenia purpura‏‎ (1 revision)
  88. CR:DOI:0d1e5dc1202ab7a7a86f7e814306e82e‏‎ (1 revision)
  89. Hand-Schüller-Christian disease‏‎ (1 revision)
  90. CR:DOI:20b1483903240f2c41f322f3dd0c9300‏‎ (1 revision)
  91. Cardiac output index‏‎ (1 revision)
  92. Transfusion-associated circulatory overload‏‎ (1 revision)
  93. Restarting anticoagulation after bleeding‏‎ (1 revision)
  94. PANDAS‏‎ (1 revision)
  95. CR:DOI:31924dec18fa6f8a5f9c873f28f52af4‏‎ (1 revision)
  96. Alkaline phosphatase‏‎ (1 revision)
  97. Pappenheimer body‏‎ (1 revision)
  98. MS‏‎ (1 revision)
  99. CR:DOI:46123634f2a85fd729368e2defc622c3‏‎ (1 revision)
  100. Ampicillin-sulbactam‏‎ (1 revision)
  101. Rituximab‏‎ (1 revision)
  102. CR:DOI:557ada687368f8167ededa806f865c2e‏‎ (1 revision)
  103. Enterococcus avium‏‎ (1 revision)
  104. STOP-Bang score‏‎ (1 revision)
  105. CR:DOI:66d3dbdffc22787fa9886b680bcbe5af‏‎ (1 revision)
  106. Ertapenem‏‎ (1 revision)
  107. Antistreptolysin O‏‎ (1 revision)
  108. CR:DOI:7aec6782ab7f966603cc1751d65939c6‏‎ (1 revision)
  109. Permethrin‏‎ (1 revision)
  110. Imiquimod‏‎ (1 revision)
  111. CR:DOI:8f3240a268c2269cf5f9bd1919a1db73‏‎ (1 revision)
  112. Faine's criteria‏‎ (1 revision)
  113. Cocaine‏‎ (1 revision)
  114. BASCULE syndrome‏‎ (1 revision)
  115. Yeasts‏‎ (1 revision)
  116. Polycythemia‏‎ (1 revision)
  117. CR:DOI:b5eea92fc03256e3a3891b33ea68ee03‏‎ (1 revision)
  118. Stable ischemic heart disease‏‎ (1 revision)
  119. Frey syndrome‏‎ (1 revision)
  120. CR:DOI:c6f06e5cb3f5f8125ec5044919cba493‏‎ (1 revision)
  121. Bevacizumab‏‎ (1 revision)
  122. GCS‏‎ (1 revision)
  123. CR:DOI:d2884a88cacf48ac2b493190c74095af‏‎ (1 revision)
  124. Debaryomyces hansenii‏‎ (1 revision)
  125. A Few Frameworks to Know‏‎ (1 revision)
  126. CR:DOI:e4b88dce4876a095de40d59ac19b0407‏‎ (1 revision)
  127. Non-alcoholic fatty liver disease‏‎ (1 revision)
  128. CR:DOI:f4828257713983f4f218bf13c82aa992‏‎ (1 revision)
  129. Tecovirimat‏‎ (1 revision)
  130. Granulomatous diseases‏‎ (1 revision)
  131. CR:DOI:0f2325db60edc6b9b12ea02b0aa425e2‏‎ (1 revision)
  132. Osteitis pubis‏‎ (1 revision)
  133. CR:DOI:223da6637bb9228360819cb97fb77f2f‏‎ (1 revision)
  134. Duffy-null associated neutrophil count‏‎ (1 revision)
  135. Cardiogenic shock‏‎ (1 revision)
  136. Resuscitation in pregnancy‏‎ (1 revision)
  137. PAR‏‎ (1 revision)
  138. Hematopoeitic malignancy‏‎ (1 revision)
  139. CR:DOI:3220ecfd9746207590bda96a386c4a36‏‎ (1 revision)
  140. Allergic bronchopulmonary aspergillosis‏‎ (1 revision)
  141. Papular-purpuric glove-and-socks syndrome‏‎ (1 revision)
  142. Hepatitis D virus‏‎ (1 revision)
  143. CR:DOI:48b240d4a5da84271e0e30de474dcd52‏‎ (1 revision)
  144. Amyloidosis‏‎ (1 revision)
  145. Robinsoniella peoriensis‏‎ (1 revision)
  146. Paroxysmal nocturnal hemoglobinuria‏‎ (1 revision)
  147. Hiccups‏‎ (1 revision)
  148. CR:DOI:55f07f8124c04d4c31455e83a0c55748‏‎ (1 revision)
  149. Meropenem-vaborbactam‏‎ (1 revision)
  150. CR:DOI:69046e808a898fdd77c4ac32e439e6b4‏‎ (1 revision)
  151. Chylothorax‏‎ (1 revision)
  152. Perioperative management of anticoagulation‏‎ (1 revision)
  153. Migraine‏‎ (1 revision)
  154. Hyperthermia‏‎ (1 revision)
  155. CR:DOI:7b64fbf5d1021ab5bc68e15d258d1c25‏‎ (1 revision)
  156. CR:DOI:9001a5594f91dd6bf04eed25ac6ece98‏‎ (1 revision)
  157. Platypnea-orthodeoxia‏‎ (1 revision)
  158. CR:DOI:9f701ec0217fe70d85c3837300571e40‏‎ (1 revision)
  159. Specific antibody deficiency‏‎ (1 revision)
  160. Mycobacterium szulgai‏‎ (1 revision)
  161. CR:DOI:b694f1fe4184f2013ae0f676769dfddb‏‎ (1 revision)
  162. Fluoroquinolones‏‎ (1 revision)
  163. Staghorn calculus‏‎ (1 revision)
  164. Myroides‏‎ (1 revision)
  165. Infective endocarditis caused by non-HACEK Gram-negative bacilli‏‎ (1 revision)
  166. CR:DOI:c7ae99a571f3ad477b69e76c8c773cf1‏‎ (1 revision)
  167. Biapical scarring‏‎ (1 revision)
  168. Sterile pyuria‏‎ (1 revision)
  169. Pressure ulcer‏‎ (1 revision)
  170. Gabapentin‏‎ (1 revision)
  171. Blue-green algae‏‎ (1 revision)
  172. CR:DOI:d3bebd2106abfdceaa1e3492cd96f23d‏‎ (1 revision)
  173. CR:DOI:e685b2d71da14c2ca90bb1aeff3daa02‏‎ (1 revision)
  174. Syncope‏‎ (1 revision)
  175. Non-alcoholic steatohepatitis‏‎ (1 revision)
  176. CR:DOI:f4aad4874d2af27c38068e31536883a4‏‎ (1 revision)
  177. Obesity hypoventilation syndrome‏‎ (1 revision)
  178. Lambert-Eaton myasthenic syndrome‏‎ (1 revision)
  179. Granulomatous lung disease‏‎ (1 revision)
  180. CMV retinitis in HIV patients‏‎ (1 revision)
  181. Diethylcarbamazine‏‎ (1 revision)
  182. CT contrast reactions‏‎ (1 revision)
  183. Thunderclap headache post-partum‏‎ (1 revision)
  184. CR:DOI:13494e2091d6ab067b36b569529e4e8c‏‎ (1 revision)
  185. Acute severe headache‏‎ (1 revision)
  186. Cancer of unknown primary‏‎ (1 revision)
  187. Togaviridae‏‎ (1 revision)
  188. Remdesivir‏‎ (1 revision)
  189. CR:DOI:234faee71b76a3460d05a93808ef21c7‏‎ (1 revision)
  190. Durvalumab‏‎ (1 revision)
  191. Aflatoxin‏‎ (1 revision)
  192. Transfusion-associated hypotension‏‎ (1 revision)
  193. PBMT‏‎ (1 revision)
  194. CR:DOI:324eb4fd5a300cb39055ab08c9026796‏‎ (1 revision)
  195. Trichophyton mentagrophytes‏‎ (1 revision)
  196. Paracentesis‏‎ (1 revision)
  197. CR:DOI:48b3c3d59b243389e5f28b00d4db15f7‏‎ (1 revision)
  198. Amyotrophic lateral sclerosis‏‎ (1 revision)
  199. Anaerobiospirillum succiniciproducens‏‎ (1 revision)
  200. Hidradenitis suppurativa‏‎ (1 revision)
  201. CR:DOI:56b67522689053f83c75be4984e0ef3a‏‎ (1 revision)
  202. Enterocutaneous fistula‏‎ (1 revision)
  203. Metabolic alkalosis‏‎ (1 revision)
  204. CR:DOI:6920036664d2ce14878b939de0c03bee‏‎ (1 revision)
  205. Ciclopirox‏‎ (1 revision)
  206. Mild cognitive impairment‏‎ (1 revision)
  207. CR:DOI:7d2e2c64e14fe7c2a7ddfcb7017ccd67‏‎ (1 revision)
  208. Monro-Kellie hypothesis‏‎ (1 revision)
  209. Immune effector cell-associated neurotoxicity syndrome‏‎ (1 revision)
  210. CR:DOI:90ca6feed9950cd48c5b12b7b7550739‏‎ (1 revision)
  211. Colchicine‏‎ (1 revision)
  212. WBC scan‏‎ (1 revision)
  213. Plazomicin‏‎ (1 revision)
  214. Multiple system atrophy‏‎ (1 revision)
  215. CR:DOI:a03981074b893893d5c9079ba13a439a‏‎ (1 revision)
  216. Polyglandular autoimmune syndromes‏‎ (1 revision)
  217. CR:DOI:b6d1517c4f96004781d4914b8f63b6cc‏‎ (1 revision)
  218. Frostbite‏‎ (1 revision)
  219. CR:DOI:c91bcc94c1cca91ebafc0d98e0111e36‏‎ (1 revision)
  220. Preterm premature rupture of membranes‏‎ (1 revision)
  221. Gabapentinoids‏‎ (1 revision)
  222. Blue sclerae‏‎ (1 revision)
  223. CR:DOI:d41a8ec870b77924908b44793d923353‏‎ (1 revision)
  224. Boutonniere deformity‏‎ (1 revision)
  225. Delayed hemolytic transfusion reaction‏‎ (1 revision)
  226. CR:DOI:e76fc2def278ad7232367b9a92790427‏‎ (1 revision)
  227. Syndrome of inappropriate ADH‏‎ (1 revision)
  228. CR:DOI:f4e55de3e93e1cc0791c0ecc51200841‏‎ (1 revision)
  229. Pyomyositis‏‎ (1 revision)
  230. CNS calcifications in neonates‏‎ (1 revision)
  231. Diffuse sclerosing conditions‏‎ (1 revision)
  232. Thyroid enlargement and nodules‏‎ (1 revision)
  233. CR:DOI:143a8a4e98ce78f59bd9439c01575f67‏‎ (1 revision)
  234. Toll-like receptors‏‎ (1 revision)
  235. Osteomyelitis in children‏‎ (1 revision)
  236. Harlequin syndrome‏‎ (1 revision)
  237. CR:DOI:2367c9a916ae67d97ccfd3dd0a19f3b6‏‎ (1 revision)
  238. Dyslipidemia‏‎ (1 revision)
  239. Transfusion-related acute lung injury‏‎ (1 revision)
  240. PEN-FAST‏‎ (1 revision)
  241. Lupus nephritis‏‎ (1 revision)
  242. CR:DOI:351be4f8e400189bf2f9e9883575b08a‏‎ (1 revision)
  243. Alpha-gal syndrome‏‎ (1 revision)
  244. Trigeminal autonomic cephalalgias‏‎ (1 revision)
  245. End-of-life order set‏‎ (1 revision)
  246. CR:DOI:4b5520861f644af6fc2c40ee3cd59320‏‎ (1 revision)
  247. Tunga penetrants‏‎ (1 revision)
  248. Parvimonas micra‏‎ (1 revision)
  249. Mechanical ventilation protocols‏‎ (1 revision)
  250. High dose ARA-C‏‎ (1 revision)
  251. CR:DOI:56f88ff55f20b5c9e5c5a475f2466bad‏‎ (1 revision)
  252. Saint Anthony’s fire‏‎ (1 revision)
  253. Hydralazine‏‎ (1 revision)
  254. CR:DOI:6b3504fe47b788cd73d9f53626512a76‏‎ (1 revision)
  255. Vasopressors and inotropes‏‎ (1 revision)
  256. Perioperative management of glucose abnormalities‏‎ (1 revision)
  257. CR:DOI:7d6ce2d7fae52c13a3710fe89fc1d156‏‎ (1 revision)
  258. Exophthalmos‏‎ (1 revision)
  259. Aseptic meningitis with genital lesions‏‎ (1 revision)
  260. Severe inflammatory response syndrome‏‎ (1 revision)
  261. Pharyngitis‏‎ (1 revision)
  262. CR:DOI:926849ee14178552466c9adb43cafb90‏‎ (1 revision)
  263. Fanconi syndrome‏‎ (1 revision)
  264. Atypical lymphocytosis‏‎ (1 revision)
  265. Warfarin‏‎ (1 revision)
  266. Skin snip biopsy‏‎ (1 revision)
  267. Multisystem inflammatory syndrome in adults‏‎ (1 revision)
  268. Bacillary angiomatosis‏‎ (1 revision)
  269. Polymyalgia rheumatica‏‎ (1 revision)
  270. CR:DOI:b9317030589eded6198a6dff29ba59a1‏‎ (1 revision)
  271. Fomepizole‏‎ (1 revision)
  272. NATO alphabet‏‎ (1 revision)
  273. Infliximab‏‎ (1 revision)
  274. CR:DOI:c961643b98eb32b71d42061b4a690ff2‏‎ (1 revision)
  275. Bilirubin‏‎ (1 revision)
  276. Pretomanid‏‎ (1 revision)
  277. Gait changes in aging‏‎ (1 revision)
  278. Body surface area‏‎ (1 revision)
  279. CR:DOI:d5c04bb4b0770dd9f52f5047e0a08bd3‏‎ (1 revision)
  280. Proteinuria‏‎ (1 revision)
  281. Brachial plexus syndrome‏‎ (1 revision)
  282. A Few Syndromes to Know‏‎ (1 revision)
  283. CR:DOI:e7d5997f6ba302aad44373195ab7f4fa‏‎ (1 revision)
  284. Klebsiella aerogenes‏‎ (1 revision)
  285. Aconite poisoning‏‎ (1 revision)
  286. CR:DOI:f4f4f2345f21b543768964b5b3a01098‏‎ (1 revision)
  287. Acute hemolytic transfusion reaction‏‎ (1 revision)
  288. Cabotegravir/rilpivirine‏‎ (1 revision)
  289. Leptotrombidium‏‎ (1 revision)
  290. HIV wasting syndrome‏‎ (1 revision)
  291. CR:DOI:14d8f96aed7b8566166d94219db9c587‏‎ (1 revision)
  292. Drain management‏‎ (1 revision)
  293. Renal biopsy‏‎ (1 revision)
  294. CR:DOI:23eb96f7b0f18d6fd85814605a856558‏‎ (1 revision)
  295. Agranulocytosis‏‎ (1 revision)
  296. Transient ischemic attack‏‎ (1 revision)
  297. CR:DOI:35deea6bca62469c53a8d1db72080a12‏‎ (1 revision)
  298. Altered mental status‏‎ (1 revision)
  299. Malakoplakia‏‎ (1 revision)
  300. Hepatocellular carcinoma‏‎ (1 revision)
  301. Anaphylaxis‏‎ (2 revisions)
  302. Tungiasis‏‎ (2 revisions)
  303. Antibiotics in sodium restriction‏‎ (2 revisions)
  304. Vaccine-induced immune thrombotic thrombocytopenia‏‎ (2 revisions)
  305. Saint Louis encephalitis virus‏‎ (2 revisions)
  306. Hyper-IgE syndrome‏‎ (2 revisions)
  307. CR:DOI:6cc99a5f77a6e9655d861ca2d1fc3c25‏‎ (2 revisions)
  308. Erythema nodosum‏‎ (2 revisions)
  309. Scombroid‏‎ (2 revisions)
  310. Phlegmasia cerulea dolens‏‎ (2 revisions)
  311. Atypical pneumonia‏‎ (2 revisions)
  312. Colitis‏‎ (2 revisions)
  313. Skull base‏‎ (2 revisions)
  314. Plesiomonas shigelloides‏‎ (2 revisions)
  315. Congenital varicella‏‎ (2 revisions)
  316. NEC‏‎ (2 revisions)
  317. Influenza virus‏‎ (2 revisions)
  318. Prevotella‏‎ (2 revisions)
  319. Abatacept‏‎ (2 revisions)
  320. Pulmonary emphysema‏‎ (2 revisions)
  321. Non-stress test‏‎ (2 revisions)
  322. Pyrazinamide‏‎ (2 revisions)
  323. Lassa virus‏‎ (2 revisions)
  324. Guillian-Barré syndrome‏‎ (2 revisions)
  325. Oral bioavailability of antimicrobials‏‎ (2 revisions)
  326. HLA-B27‏‎ (2 revisions)
  327. Drive + Fly‏‎ (2 revisions)
  328. Acute toxic leukoencephalopathy‏‎ (2 revisions)
  329. Renal calculi‏‎ (2 revisions)
  330. Agrobacterium‏‎ (2 revisions)
  331. Transient ischemic attack and minor stroke‏‎ (2 revisions)
  332. PREDICT score‏‎ (2 revisions)
  333. Ectopic pregnancy‏‎ (2 revisions)
  334. Hepatopulmonary syndrome‏‎ (2 revisions)
  335. Pasteurella multocida‏‎ (2 revisions)
  336. Chronic fatigue syndrome‏‎ (2 revisions)
  337. Salicylate-ASA toxicity‏‎ (2 revisions)
  338. Methanol toxicity‏‎ (2 revisions)
  339. Aortic stenosis‏‎ (2 revisions)
  340. Aspergillus oryzae‏‎ (2 revisions)
  341. Clostridium chauvoei‏‎ (2 revisions)
  342. Immunization after hematopoietic stem cell transplantation‏‎ (2 revisions)
  343. Fasciola hepatica‏‎ (2 revisions)
  344. CR:DOI:a55f83309a6e6f4ddbc632334a718bda‏‎ (2 revisions)
  345. Conjunctivitis‏‎ (2 revisions)
  346. Mycobacterium ulcerans‏‎ (2 revisions)
  347. Infections associated with rabbits‏‎ (2 revisions)
  348. Galactorrhea‏‎ (2 revisions)
  349. (1,3)-β-D-glucan‏‎ (2 revisions)
  350. Subdural empyema‏‎ (2 revisions)
  351. Neutrophilia‏‎ (2 revisions)
  352. Pulmonary function tests‏‎ (2 revisions)
  353. Diabetes in pregnancy‏‎ (2 revisions)
  354. Thalassemia‏‎ (2 revisions)
  355. Ochrobactrum‏‎ (2 revisions)
  356. Osteoporosis‏‎ (2 revisions)
  357. Hartford nomogram‏‎ (2 revisions)
  358. Rheumatoid arthritis‏‎ (2 revisions)
  359. Paralytic shellfish poisoning‏‎ (2 revisions)
  360. Mallampati score‏‎ (2 revisions)
  361. Hepatorenal syndrome‏‎ (2 revisions)
  362. Patau syndrome‏‎ (2 revisions)
  363. Antiepileptic drugs‏‎ (2 revisions)
  364. Vaginal discharge‏‎ (2 revisions)
  365. Methemoglobinemia‏‎ (2 revisions)
  366. Hypercalcemia‏‎ (2 revisions)
  367. Aspergillus sojae‏‎ (2 revisions)
  368. Weissella‏‎ (2 revisions)
  369. Pleural effusion in allogeneic hematopoietic stem cell transplantation‏‎ (2 revisions)
  370. Infection-associated glomerulonephritis‏‎ (2 revisions)
  371. Mycology lab safety‏‎ (2 revisions)
  372. Infections associated with racoons‏‎ (2 revisions)
  373. NYHA classes‏‎ (2 revisions)
  374. Intrinsic vancomycin resistance‏‎ (2 revisions)
  375. Nevirapine‏‎ (2 revisions)
  376. Ixekizumab‏‎ (2 revisions)
  377. Germ tube test‏‎ (2 revisions)
  378. Pulmonary hypertension‏‎ (2 revisions)
  379. Klebsiella variicola‏‎ (2 revisions)
  380. Gram-negative diplococci‏‎ (2 revisions)
  381. Burning mouth syndrome‏‎ (2 revisions)
  382. Diabetes insipidus‏‎ (2 revisions)
  383. Pyrrolidonyl arylamidase test‏‎ (2 revisions)
  384. Gynecomastia‏‎ (2 revisions)
  385. Calcium channel blocker toxicity‏‎ (2 revisions)
  386. Leuconostoc mesenteroides‏‎ (2 revisions)
  387. Acute urinary retention‏‎ (2 revisions)
  388. Capnocytophaga canimorsus‏‎ (2 revisions)
  389. Liver disease in HIV‏‎ (2 revisions)
  390. Head and neck cancers‏‎ (2 revisions)
  391. Catamenial epilepsy‏‎ (2 revisions)
  392. Lymphadenopathy in children‏‎ (2 revisions)
  393. Hemorrhage‏‎ (2 revisions)
  394. Edwards' syndrome‏‎ (2 revisions)
  395. Alzheimer disease‏‎ (2 revisions)
  396. Enoxaparin‏‎ (2 revisions)
  397. Angioimmunoblastic T-cell lymphoma‏‎ (2 revisions)
  398. Chlamydia psittaci‏‎ (2 revisions)
  399. Ulcerative colitis‏‎ (2 revisions)
  400. Home oxygen‏‎ (2 revisions)
  401. Hypercalcemia of malignancy‏‎ (2 revisions)
  402. Asplenia and hyposplenia‏‎ (2 revisions)
  403. Myasthenia gravis‏‎ (2 revisions)
  404. Splenic hydatid cyst‏‎ (2 revisions)
  405. Mycoplasma‏‎ (2 revisions)
  406. Cunninghamella bertholletiae‏‎ (2 revisions)
  407. Nicotine withdrawal‏‎ (2 revisions)
  408. Brentuximab vedotin‏‎ (2 revisions)
  409. Sézary syndrome‏‎ (2 revisions)
  410. Non-typhoidal Salmonella vascular infection score‏‎ (2 revisions)
  411. Kloeckera apiculata‏‎ (2 revisions)
  412. CR:DOI:fbacb1b82c9cb607c04d96825dc511c9‏‎ (2 revisions)
  413. Ocular larva migrans‏‎ (2 revisions)
  414. Toxic alcohols‏‎ (2 revisions)
  415. Paraneoplastic limbic encephalitis‏‎ (2 revisions)
  416. Mange‏‎ (2 revisions)
  417. Hereditary angioedema‏‎ (2 revisions)
  418. Horner syndrome‏‎ (2 revisions)
  419. CR:DOI:597122a60ca1220bc34eb933860bd38f‏‎ (2 revisions)
  420. Pericardial effusion‏‎ (2 revisions)
  421. Aplastic anemia‏‎ (2 revisions)
  422. Venous thromboembolism‏‎ (2 revisions)
  423. Shock‏‎ (2 revisions)
  424. Immunodeficiency‏‎ (2 revisions)
  425. Autism spectrum disorder‏‎ (2 revisions)
  426. Complement deficiency‏‎ (2 revisions)
  427. Fibromyalgia‏‎ (2 revisions)
  428. Porphyria‏‎ (2 revisions)
  429. Bispecific T-cell engager‏‎ (2 revisions)
  430. Cursive seizure‏‎ (2 revisions)
  431. Ixodes pacificus‏‎ (2 revisions)
  432. Brevibacillus‏‎ (2 revisions)
  433. Diabetes mellitus type 2‏‎ (2 revisions)
  434. HANDOC score‏‎ (2 revisions)
  435. Acute kidney injury in renal transplant‏‎ (2 revisions)
  436. Caliciviridae‏‎ (2 revisions)
  437. Tick paralysis‏‎ (2 revisions)
  438. Toxic megacolon‏‎ (2 revisions)
  439. Outpatient Parenteral Antimicrobial Therapy (OPAT) (IDSA 2018)‏‎ (2 revisions)
  440. Hepatic encephalopathy‏‎ (2 revisions)
  441. Manogepix‏‎ (2 revisions)
  442. Hereditary hemochromatosis‏‎ (2 revisions)
  443. Chloroquine‏‎ (2 revisions)
  444. Pazopanib‏‎ (2 revisions)
  445. Medications causing vision loss‏‎ (2 revisions)
  446. Apophysomyces elegans‏‎ (2 revisions)
  447. Citrobacter freundii‏‎ (2 revisions)
  448. Venous thromboembolism in pregnancy‏‎ (2 revisions)
  449. Secondary hemolytic-uremic syndrome‏‎ (2 revisions)
  450. Ibrutinib‏‎ (2 revisions)
  451. Clostridium tertium‏‎ (2 revisions)
  452. Short bowel syndrome‏‎ (2 revisions)
  453. Autoimmune hemolytic anemia‏‎ (2 revisions)
  454. Spondyloarthritis‏‎ (2 revisions)
  455. Porphyria cutanea tarda‏‎ (2 revisions)
  456. Mycoplasma phocacerebrale‏‎ (2 revisions)
  457. Neonatal HIV‏‎ (2 revisions)
  458. Substitute decision maker‏‎ (2 revisions)
  459. Pruritus‏‎ (2 revisions)
  460. Brevundimonas‏‎ (2 revisions)
  461. Normal anion gap metabolic acidosis‏‎ (2 revisions)
  462. CR:DOI:09649f204e0f789481cbf2b6e9852750‏‎ (2 revisions)
  463. Dix-Hallpike manoeuvre‏‎ (2 revisions)
  464. California encephalitis virus‏‎ (2 revisions)
  465. Carbapenemase-producing Enterobacteriaceae‏‎ (2 revisions)
  466. Renal tubular acidosis‏‎ (2 revisions)
  467. Loop diuretic‏‎ (2 revisions)
  468. CR:DOI:2d3c452047be5089ceb85dbafbd2293f‏‎ (2 revisions)
  469. Rhinosporidium seeberi‏‎ (2 revisions)
  470. CR:DOI:60c42ee946fc6f8b9ba4d0e3baaaf7f4‏‎ (2 revisions)
  471. Epidural hemorrhage‏‎ (2 revisions)
  472. Hyperkalemia‏‎ (2 revisions)
  473. Asthma in pregnancy‏‎ (2 revisions)
  474. Viral hepatitis‏‎ (2 revisions)
  475. Fetal heart tracing‏‎ (2 revisions)
  476. Filgrastim‏‎ (2 revisions)
  477. Zoonotic infections‏‎ (2 revisions)
  478. Spontaneous abortion‏‎ (2 revisions)
  479. Behçet disease‏‎ (2 revisions)
  480. Staphylococcus aureus endocarditis‏‎ (2 revisions)
  481. Bladder pain syndrome‏‎ (2 revisions)
  482. Pseudocowpox virus‏‎ (2 revisions)
  483. Normal labour and delivery‏‎ (2 revisions)
  484. Dobutamine‏‎ (2 revisions)
  485. Calvaria‏‎ (2 revisions)
  486. CR:DOI:1da74b622a953e9ec15f52a5d9406f23‏‎ (2 revisions)
  487. Resless leg syndrome‏‎ (2 revisions)
  488. Low back pain‏‎ (2 revisions)
  489. Eagle phenomenon‏‎ (2 revisions)
  490. Treponema pallidum‏‎ (2 revisions)
  491. Rhinovirus‏‎ (2 revisions)
  492. Palivizumab‏‎ (2 revisions)
  493. Amikacin‏‎ (2 revisions)
  494. Hereditary thrombophilias‏‎ (2 revisions)
  495. Cholinergic toxidrome‏‎ (2 revisions)
  496. Pediculus humanus‏‎ (2 revisions)
  497. Meningioma‏‎ (2 revisions)
  498. Peripheral neuropathy‏‎ (2 revisions)
  499. Cloxacillin‏‎ (2 revisions)
  500. Smoldering myeloma‏‎ (2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)